ACADIA Pharmaceuticals Inc. (ACAD)

NASDAQ: ACAD · IEX Real-Time Price · USD

16.99

+0.17 (1.01%)

At close: Apr 22, 2024, 4:00 PM

17.17

+0.18 (1.06%)

After-hours: Apr 22, 2024, 6:35 PM EDT

ACADIA Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2001
Net Income	-61.29	-215.98	-167.87	-281.58	-235.26	-245.19	-289.4	-271.39	-164.44	-92.48	Upgrade
Depreciation & Amortization	5.55	2.03	3.34	2.93	2.77	3.01	2.71	1.83	0.65	0.21	Upgrade
Share-Based Compensation	66.42	68.2	63.62	84.42	82.27	81.56	75.53	54.67	39.95	16.04	Upgrade
Other Operating Activities	6.02	31.71	-24.75	58.06	-0.9	-6.85	-6.6	6.49	2.05	9.8	Upgrade
Operating Cash Flow	16.7	-114.04	-125.66	-136.17	-151.13	-167.47	-217.76	-208.41	-121.8	-66.43	Upgrade
Capital Expenditures	-0.05	0	-1.12	-7.59	-1.13	-2.1	-0.81	-1.51	-2.14	-0.18	Upgrade
Change in Investments	72.05	73.24	-69.98	200.1	-164.71	-69.39	93.29	-252.42	149.71	-87.09	Upgrade
Other Investing Activities	-40	-	-	-	-	-	-	-8	-	-	Upgrade
Investing Cash Flow	32	73.24	-71.1	192.51	-165.84	-71.49	92.47	-261.92	147.57	-87.27	Upgrade
Share Issuance / Repurchase	25.13	8.2	18.16	81	371.85	306.65	31.19	518.9	14.55	203.85	Upgrade
Other Financing Activities	-	-	-	-	-	-	-	14.92	-0.05	-	Upgrade
Financing Cash Flow	25.13	8.2	18.16	81	371.85	306.65	31.19	533.81	14.5	203.85	Upgrade
Exchange Rate Effect	-0.02	0.01	0.01	-0.01	0	0	-0.01	0	0.01	0	Upgrade
Net Cash Flow	73.81	-32.59	-178.59	137.33	54.88	67.69	-94.1	63.48	40.28	50.15	Upgrade
Free Cash Flow	16.65	-114.04	-126.78	-143.75	-152.26	-169.57	-218.57	-209.91	-123.94	-66.61	Upgrade
Free Cash Flow Margin	2.29%	-22.05%	-26.19%	-32.54%	-44.90%	-75.77%	-174.99%	-1211.21%	-203173.77%	-55511.67%	Upgrade
Free Cash Flow Per Share	0.10	-0.70	-0.79	-0.91	-1.03	-1.34	-1.78	-1.81	-1.23	-0.69	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).